Evidence map›Paper›PMID 27429999›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2016

Numerical observer for atherosclerotic plaque classification in spectral computed tomography.

Auranuch Lorsakul, Georges El Fakhri, William Worstell, Jinsong Ouyang, Yothin Rakvongthai, Andrew F Laine, Quanzheng Li

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The role of extra-foveal processing in 3D imaging.Proceedings of SPIE--the International Society for Optical Engineering · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Auranuch LorsakulMassachusetts General Hospital, Division of Nuclear Medicine and Molecular Imaging, Gordon Center for Medical Imaging, 55 Fruit Street, White 427, Boston, Massachusetts 02114, United States; Columbia University, Department of Biomedical Engineering, 1210 Amsterdam Avenue, New York, New York 10027, United States.
Georges El FakhriMassachusetts General Hospital, Division of Nuclear Medicine and Molecular Imaging, Gordon Center for Medical Imaging, 55 Fruit Street, White 427, Boston, Massachusetts 02114, United States; Harvard Medical School, Department of Radiology, 25 Shattuck Street, Boston, Massachusetts 02115, United States.
William WorstellPhotoDiagnostic System Inc. , 85 Swanson Road, Boxborough, Massachusetts 01719, United States.
Jinsong OuyangMassachusetts General Hospital, Division of Nuclear Medicine and Molecular Imaging, Gordon Center for Medical Imaging, 55 Fruit Street, White 427, Boston, Massachusetts 02114, United States; Harvard Medical School, Department of Radiology, 25 Shattuck Street, Boston, Massachusetts 02115, United States.
Yothin RakvongthaiMassachusetts General Hospital, Division of Nuclear Medicine and Molecular Imaging, Gordon Center for Medical Imaging, 55 Fruit Street, White 427, Boston, Massachusetts 02114, United States; Chulalongkorn University, Department of Radiology, Faculty of Medicine, 1873 Rama 4 Road, Pathumwan, Bangkok 10330, Thailand.
Andrew F LaineColumbia University , Department of Biomedical Engineering, 1210 Amsterdam Avenue, New York, New York 10027, United States.
Quanzheng LiMassachusetts General Hospital, Division of Nuclear Medicine and Molecular Imaging, Gordon Center for Medical Imaging, 55 Fruit Street, White 427, Boston, Massachusetts 02114, United States; Harvard Medical School, Department of Radiology, 25 Shattuck Street, Boston, Massachusetts 02115, United States.

Funding

Quantitative Oncologic PET-MRR01CA165221 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2012 to 2023
$4.7M
Quantitative Simultaneous Cardiac PET-MRR01HL118261 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI OUYANG, JINSONG · 2014 to 2018
$2.6M
Quantitative Cardiac PETR01HL110241 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2011 to 2014
$1.9M
Quantitative Methods for Clinical Whole Body Dynamic PETR01EB013293 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI LI, QUANZHENG · 2012 to 2015
$1.5M
NCI NIH HHS R01 CA165221NHLBI NIH HHS R01 HL110241NHLBI NIH HHS R01 HL118261NIBIB NIH HHS R01 EB013293
6 · The paper itself

Abstract

Spectral computed tomography (SCT) generates better image quality than conventional computed tomography (CT). It has overcome several limitations for imaging atherosclerotic plaque. However, the literature evaluating the performance of SCT based on objective image assessment is very limited for the task of discriminating plaques. We developed a numerical-observer method and used it to assess performance on discrimination vulnerable-plaque features and compared the performance among multienergy CT (MECT), dual-energy CT (DECT), and conventional CT methods. Our numerical observer was designed to incorporate all spectral information and comprised two-processing stages. First, each energy-window domain was preprocessed by a set of localized channelized Hotelling observers (CHO). In this step, the spectral image in each energy bin was decorrelated using localized prewhitening and matched filtering with a set of Laguerre-Gaussian channel functions. Second, the series of the intermediate scores computed from all the CHOs were integrated by a Hotelling observer with an additional prewhitening and matched filter. The overall signal-to-noise ratio (SNR) and the area under the receiver operating characteristic curve (AUC) were obtained, yielding an overall discrimination performance metric. The performance of our new observer was evaluated for the particular binary classification task of differentiating between alternative plaque characterizations in carotid arteries. A clinically realistic model of signal variability was also included in our simulation of the discrimination tasks. The inclusion of signal variation is a key to applying the proposed observer method to spectral CT data. Hence, the task-based approaches based on the signal-known-exactly/background-known-exactly (SKE/BKE) framework and the clinical-relevant signal-known-statistically/background-known-exactly (SKS/BKE) framework were applied for analytical computation of figures of merit (FOM). Simulated data of a carotid-atherosclerosis patient were used to validate our methods. We used an extended cardiac-torso anthropomorphic digital phantom and three simulated plaque types (i.e., calcified plaque, fatty-mixed plaque, and iodine-mixed blood). The images were reconstructed using a standard filtered backprojection (FBP) algorithm for all the acquisition methods and were applied to perform two different discrimination tasks of: (1) calcified plaque versus fatty-mixed plaque and (2) calcified plaque versus iodine-mixed blood. MECT outperformed DECT and conventional CT systems for all cases of the SKE/BKE and SKS/BKE tasks (all [Formula: see text]). On average of signal variability, MECT yielded the SNR improvements over other acquisition methods in the range of 46.8% to 65.3% (all [Formula: see text]) for FBP-Ramp images and 53.2% to 67.7% (all [Formula: see text]) for FBP-Hanning images for both identification tasks. This proposed numerical observer combined with our signal variability framework is promising for assessing material characterization obtained through the additional energy-dependent attenuation information of SCT. These methods can be further extended to other clinical tasks such as kidney or urinary stone identification applications.

Indexed as

channelized Hotelling observerclassification taskimage quality assessmentnumerical observerplaque imagingspectral computed tomography

Identifiers

PMID27429999
PMCPMC4940624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.